Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cost-Effectiveness of Comprehensive Quadruple Therapy for Heart Failure With Reduced Ejection Fraction
Neal M. Dixit, Neil U. Parikh, Boback Ziaeian, et al.
JACC Heart Failure (2023) Vol. 11, Iss. 5, pp. 541-551
Open Access | Times Cited: 21

Showing 21 citing articles:

The Effect of Using a Remote Patient Management Platform in Optimizing Guideline-Directed Medical Therapy in Heart Failure Patients
Darshan H. Brahmbhatt, Heather J. Ross, Mary P. O’Sullivan, et al.
JACC Heart Failure (2024) Vol. 12, Iss. 4, pp. 678-690
Open Access | Times Cited: 9
Potential global impact of sodium–glucose cotransporter‐2 inhibitors in heart failure
Khawaja M. Talha, Javed Butler, Stephen J. Greene, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 7, pp. 999-1009
Open Access | Times Cited: 20
The economics of heart failure care
Wei Chen, Paul A. Heidenreich, Alexander T. Sandhu
Progress in Cardiovascular Diseases (2024) Vol. 82, pp. 90-101
Open Access | Times Cited: 5
The clinical and pharmacoeconomic impact of established and novel heart failure therapies
Mauro Acquaro, Annalisa Turco, Leonardo De Luca
European Heart Journal Supplements (2025) Vol. 27, Iss. Supplement_1, pp. i132-i136
Open Access
The economic impact of the pharmacist in heart failure ambulatory care clinics: A scoping review
Justine Brasseur‐Masse, Abigail Duguay‐Gentile, Cheng Gao, et al.
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (2025)
Open Access
Economic Modeling Analysis of an Intensive GDMT Optimization Program in Hospitalized Heart Failure Patients
Neal M. Dixit, Neil U. Parikh, Boback Ziaeian, et al.
Circulation Heart Failure (2023) Vol. 16, Iss. 12
Open Access | Times Cited: 8
Health economics in nursing research: what you need to know to include economic evaluation methodology in your research
Norma B. Bulamu, Billingsley Kaambwa, Hannah Beks, et al.
European Journal of Cardiovascular Nursing (2024) Vol. 23, Iss. 1, pp. 99-106
Open Access | Times Cited: 2
Health equity in heart failure
Aishwarya Vijay, Clyde W. Yancy
Progress in Cardiovascular Diseases (2024) Vol. 82, pp. 55-60
Closed Access | Times Cited: 2
The March Toward Improved Heart Failure Outcomes Requires an Emphasis on Affordability
Julia H.A. Foote, Dhruv S. Kazi
JACC Heart Failure (2024) Vol. 12, Iss. 7, pp. 1238-1241
Closed Access | Times Cited: 2
County-Level Variation in Triple Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction
Rishi Desai, Danielle Stonely, Naira Ikram, et al.
JACC Advances (2024) Vol. 3, Iss. 7, pp. 101014-101014
Open Access | Times Cited: 2
Hospital Heart Failure Medical Therapy Score and Associated Clinical Outcomes and Costs
Vincenzo B. Polsinelli, Jie‐Lena Sun, Stephen J. Greene, et al.
JAMA Cardiology (2024) Vol. 9, Iss. 11, pp. 1029-1029
Closed Access | Times Cited: 2
Patient Perspectives on Digital Interventions to Manage Heart Failure Medications: The VITAL-HF Pilot
Marc D. Samsky, Renee Leverty, James M. Gray, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4676-4676
Open Access | Times Cited: 6
New era in heart failure management: implementing cutting-edge therapies effectively
Anastasia Shchendrygina, Clara Saldarriaga
Open Heart (2024) Vol. 11, Iss. 1, pp. e002659-e002659
Open Access | Times Cited: 1
Cost-Effectiveness of New Quadruple Therapy Compared With Standard Treatment for Patients With Heart Failure in China
Yun Huang, Hua Zhou, Chongbo Fang, et al.
Journal of Cardiovascular Pharmacology (2023) Vol. 83, Iss. 1, pp. 86-92
Closed Access | Times Cited: 2
Outcomes with guideline-directed medical therapy and cardiac implantable electronic device therapies for patients with heart failure with reduced ejection fraction
John Mignone, Kevin Alexander, Michael Dobbles, et al.
Heart Rhythm O2 (2024) Vol. 5, Iss. 3, pp. 168-173
Open Access
Overcoming clinical inertia with SGLT‐2 inhibitors: Strategies to accelerate adoption in heart failure
Byron Crowe, Shantum Misra, Clement Lee
Journal of Hospital Medicine (2024) Vol. 20, Iss. 1, pp. 67-70
Closed Access
Qualitative Evaluation to Understand Barriers and Facilitators to Prescribing Angiotensin Receptor-Neprilysin Inhibitors (ARNi) and Sodium-Glucose Cotransporter Inhibitors (SGLT2i) in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF)
Apoorva Pradhan, Mia E. Lussier, My Huong Nguyen, et al.
Journal of the American Pharmacists Association (2024) Vol. 64, Iss. 6, pp. 102224-102224
Open Access
Metabolome and microbiome analyses reveal the efficacy of Shen‐Fu formula in treating heart failure
Nana Li, Yuting Huang, Feng Chen, et al.
Biomedical Chromatography (2024) Vol. 38, Iss. 12
Closed Access
The Value of Comprehensive Guideline-Directed Therapy for Heart Failure With Reduced Ejection Fraction
Dhruv S. Kazi, Paul A. Heidenreich
JACC Heart Failure (2023) Vol. 11, Iss. 5, pp. 552-554
Open Access | Times Cited: 1
Sodium–glucose cotransporter‐2 inhibitors for heart failure: Time is up for indulging in wishful thinking
Jesús Álvarez‐García
European Journal of Heart Failure (2023) Vol. 25, Iss. 7, pp. 1010-1011
Closed Access
Resource Use Following Atrial Fibrillation Ablation: Spending Resources to Save Resources
Emily P. Zeitler, Michael Kim
Journal of the American Heart Association (2023) Vol. 12, Iss. 18
Open Access
Page 1

Scroll to top